Related Experiment Video
Updated: Jul 15, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
The Inhibition Mechanism of Berberine on Acetylcholinesterase With Kinetic, Spectroscopic, Molecular Simulation
Zhe Tang1, Benting Zhao2, Cun Luo2
1School of Chemistry Chemical Engineering, Yancheng Institute of Technology, Yancheng, Jiangsu Province, China.
Abstract:
This study investigated the molecular mechanism underlying berberine (BER)-mediated inhibition of acetylcholinesterase (AChE) and its synergistic interaction with galantamine hydrobromide (GAL). Heatmap-based dose-response analysis revealed significant synergistic inhibitory effect of BER and GAL on AChE activity at concentrations of 4.0 μM BER and 8.0 μM GAL. Enzyme kinetic analyses demonstrated that GAL, BER, and the BER GAL combination exhibited competitive, non-competitive, and mixed-type inhibition modes against AChE, respectively. Fluorescence quenching and circular dichroism spectroscopy confirmed high affinity binding of BER to AChE, predominantly stabilized by hydrophobic interactions and hydrogen bonding resulting in conformational alterations in the enzyme structure. Molecular docking simulations further indicated that BER binding affects the solvent-accessible surface area of AChE, induces microenvironmental changes within AChE, and enhances its hydrophobicity. In addition, molecular docking simulations confirmed that BER bound to the peripheral anionic site (PAS) (Trp286, Tyr341, Tyr124) of AChE inducing a more flexible enzyme conformation that facilitates more sites of BER binding. This structural loosening hinders substrate access to the catalytic active site (CAS), thereby inhibiting AChE's catalytic activity. BER mediated PAS remodeling, which enhances GAL's binding affinity for the CAS and cooperatively destabilizes the AChE structure ultimately disrupting substrate-enzyme interactions.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...